Real-world evidence: A review of clinical experience in metastatic gastric cancer second-line treatment with ramucirumab

Miguel Quintana-Quintana; María Consuelo Díaz-Romero; Christian Patricio Camacho-Limas; Laura Torrecillas-Torres; Erika Ruiz-García; José Antonio Acevedo-Delgado; Guillermo Olivares-Beltrán; Francisco Medina-Soto; Jorge Alberto Robles-Aviña; Pedro Sobrevilla; Juan Cruz-Baca; Alicia Espinoza-Acosta; Daniel Motola-Kuba; Ramiro Magaña-Serrano; Juan Paulo Ceja-García; Alejandro Molina-Franco; Leticia Vázquez-Cortes; Julia Angelina Sáenz-Frías; Iván Romerico González-Espinoza; Eduardo Téllez-Bernal; Eva Lucia Willars-Inman; Luis Javier Barajas-Figueroa; Flor de Thé Bustamante-Valles; Benjamín Dávalos-Félix; Saúl Campos-Gómez; Germán Calderillo-Ruiz

doi:10.24875/j.gamo.m17000069

Real-world evidence: A review of clinical experience in metastatic gastric cancer second-line treatment with ramucirumab

Gaceta Mexicana de Oncolog�a ◽

10.24875/j.gamo.m17000069 ◽

2019 ◽

Vol 16 (3) ◽

Author(s):

Miguel Quintana-Quintana ◽

María Consuelo Díaz-Romero ◽

Christian Patricio Camacho-Limas ◽

Laura Torrecillas-Torres ◽

Erika Ruiz-García ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Experience ◽

Real World ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Second Line ◽

Real World Evidence

Download Full-text

Second-line treatment efficacy in elderly vs. non-elderly advanced gastric cancer patients: an Italian multicentre real-world study

Annals of Oncology ◽

10.1093/annonc/mdx425.004 ◽

2017 ◽

Vol 28 ◽

pp. vi45

Author(s):

V. Fanotto ◽

M. Uccello ◽

L. Fornaro ◽

L. Rimassa ◽

F. Leone ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Real World ◽

Treatment Efficacy ◽

Line Treatment ◽

Second Line ◽

Gastric Cancer Patients

Download Full-text

Assessing Type and Impact of Biases Potentially Occurring when Analyzing Real World Evidence: The Case of Second Line Treatment for Ovarian Cancer

Value in Health ◽

10.1016/j.jval.2018.04.1446 ◽

2018 ◽

Vol 21 ◽

pp. S213

Author(s):

F Kuehne ◽

M Arvandi ◽

LM Hess ◽

DE Faries ◽

R Matteucci Gothe ◽

...

Keyword(s):

Ovarian Cancer ◽

Real World ◽

Line Treatment ◽

Second Line ◽

Real World Evidence

Download Full-text

PCN2 First-LINE Maintenance and Second-LINE Treatment of Advanced or Metastatic Gastric Cancer: A Systematic Review of Literature

Value in Health ◽

10.1016/j.jval.2020.08.139 ◽

2020 ◽

Vol 23 ◽

pp. S421

Author(s):

B. Singh ◽

S. Attri ◽

G. Kaur ◽

J. Flynn

Keyword(s):

Gastric Cancer ◽

Systematic Review ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Second Line ◽

Review Of Literature ◽

First Line

Download Full-text

Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2018.11.009 ◽

2019 ◽

Vol 10 (4) ◽

pp. 591-597 ◽

Cited By ~ 1

Author(s):

Valentina Fanotto ◽

Lorenzo Fornaro ◽

Roberto Bordonaro ◽

Gerardo Rosati ◽

Lorenza Rimassa ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Real World ◽

Treatment Efficacy ◽

Older Patients ◽

Line Treatment ◽

Second Line

Download Full-text

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)

Gastric Cancer ◽

10.1007/s10120-021-01276-4 ◽

2022 ◽

Author(s):

Bum Jun Kim ◽

Hee-Jung Jee ◽

Sun Young Rha ◽

Hye Sook Han ◽

Min-Hee Ryu ◽

...

Keyword(s):

Gastric Cancer ◽

Real World ◽

Subgroup Analysis ◽

Line Treatment ◽

Second Line ◽

Her2 Positive

Download Full-text

Is ramucirumab still the only second-line treatment in metastatic gastric cancer?

Pharmacogenomics ◽

10.2217/pgs-2020-0118 ◽

2020 ◽

Vol 21 (17) ◽

pp. 1203-1206

Author(s):

Khalil El Gharib ◽

Hampig Raphael Kourie

Keyword(s):

Gastric Cancer ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Second Line

Download Full-text

An investigator initiated multicenter phase I/II study of paclitaxel, ramucirumab with nivolumab as the second-line treatment in patients with metastatic gastric cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps4131 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS4131-TPS4131 ◽

Cited By ~ 1

Author(s):

Tomohiro Nishina ◽

Shuichi Hironaka ◽

Shigenori Kadowaki ◽

Takeharu Yamanaka ◽

Takako Eguchi Nakajima

Keyword(s):

Gastric Cancer ◽

Phase I ◽

Metastatic Gastric Cancer ◽

Line Treatment ◽

Second Line ◽

Multicenter Phase

Download Full-text

Comparative Effectiveness Analysis Using Real World Evidence (RWE) and Applying a Causal Marginal Structural Model: the Case of Second-Line Treatment in Patients with Ovarian Cancer

Value in Health ◽

10.1016/j.jval.2018.04.108 ◽

2018 ◽

Vol 21 ◽

pp. S18

Author(s):

U Siebert ◽

F Kuehne ◽

M Arvandi ◽

LM Hess ◽

DE Faries ◽

...

Keyword(s):

Ovarian Cancer ◽

Real World ◽

Comparative Effectiveness ◽

Structural Model ◽

Line Treatment ◽

Second Line ◽

Marginal Structural Model ◽

Effectiveness Analysis ◽

Real World Evidence ◽

Comparative Effectiveness Analysis

Download Full-text

Clinical experience: Ramucirumab with FOLFIRI/XELIRI as a second-line for patients with metastatic gastric cancer

Annals of Oncology ◽

10.1093/annonc/mdz247.128 ◽

2019 ◽

Vol 30 ◽

pp. v309

Author(s):

T. Titova ◽

N. Besova ◽

E. Artamonova ◽

E. Perminova

Keyword(s):

Gastric Cancer ◽

Clinical Experience ◽

Metastatic Gastric Cancer ◽

Second Line

Download Full-text

P-77 Real-world evidence on second-line treatment of fluoropyrimidine, irinotecan, and anti-VEGF antibody for metastatic colorectal cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.04.159 ◽

2020 ◽

Vol 31 ◽

pp. S114

Author(s):

T. Yamanaka ◽

K. Yamazaki ◽

T. Hamano

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Real World ◽

Line Treatment ◽

Second Line ◽

Anti Vegf ◽

Real World Evidence

Download Full-text